Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 to reflect a new page version.SummaryDifference0.0%

- Check14 days agoChange DetectedThe revision tag was updated: 'Revision: v3.6.2' was added and the previous 'Revision: v3.6.0' tag was removed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded user guidance sections and a recruitment-status notice to improve navigation and participation clarity. Updated formatting of the Intervention/Treatment heading and bumped the site revision from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check35 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5. This indicates a new release/version of the software or documentation.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a newer version of the page content.SummaryDifference0.0%

- Check71 days agoChange DetectedA new revision tag v3.5.3 was added and the previous tag v3.5.2 was removed, indicating an update to the page's revision metadata rather than changes to the visible study content.SummaryDifference0.0%

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.